| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |